Market Overview The hypertriglyceridemia market is evolving as familial chylomicronemia reshapes industry dynamics and clinical practice. The Hypertriglyceridemia Market is projected to grow substantially through 2030, driven by metabolic syndrome prevalence, severe hypertriglyceridemia recognition, and novel target discovery supporting ultra-rare disease advancement across lipoprotein lipase...